# A Study of Intravenous XMT-1107 in Patients With Advanced Solid Tumors

> **NCT01011972** · PHASE1 · COMPLETED · sponsor: **Mersana Therapeutics** · enrollment: 52 (actual)

## Conditions studied

- Neoplasm Metastasis

## Interventions

- **DRUG:** XMT-1107

## Key facts

- **NCT ID:** NCT01011972
- **Lead sponsor:** Mersana Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2018-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01011972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01011972, "A Study of Intravenous XMT-1107 in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01011972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*